States Push FDA To Hone Compounding Oversight Plan

Law360, New York (December 19, 2012, 7:09 PM EST) -- State officials expressed skepticism Wednesday about the U.S. Food and Drug Administration's plan to split oversight of compounding pharmacies following a deadly meningitis outbreak, saying different types of compounding should be more precisely defined.

The FDA convened a meeting with representatives from all 50 states after Commissioner Margaret Hamburg told lawmakers she wanted the agency to have jurisdiction over so-called nontraditional compounders, with states retaining jurisdiction over traditional compounders. Congress is considering an overhaul of compounding regulations in the wake of a meningitis outbreak linked to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.